HIMSS Analytics launches market intelligence tool

HIMSS Analytics has launched Logic, a global healthcare IT market intelligence tool.

The tool was collaboratively built with hospitals and health systems and allows healthcare providers, healthcare IT companies, governmental and education organizations along with investors to gain crucial insights for guiding healthcare IT strategies, according to the organization.  

Logic will provide insight into predictive modeling, benchmarks and value optimization of health IT, including ranking and adoption of the HIMSS Analytics Electronic Medical Record Adoption Model (EMRAM). Logic builds off the current HIMSS Analytics Database, which stores key data insights from provider institutions across the country. New features include more visualizations and customizable dashboards that generate actionable market intelligence on-demand, such as usage, first-time purchases, upgrades or replacements and key healthcare decisions makers.

“Our customers have come to rely on us for the most cutting edge, reliable insights and data. Now, with Logic, the industry can access actionable data faster than any other resource in the market,” said Blain Newton, HIMSS Analytics COO, in a release. “Logic is also unique in that it offers benefits for organizations both large and small--tech giants and emerging companies alike can leverage Logic to improve their understanding of the marketplace.”

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.